v3.25.3
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 

   2025   2024   2025   2024 
   For the Nine Months Ended
September 30,
   For the Three Months Ended
September 30,
 
   2025   2024   2025   2024 
Convertible notes payable   1,774,896    509,504    1,774,896    509,504 
Preferred stock   641,577    301,900    641,577    301,900 
Restricted stock units   90,473    41,566    90,473    12,424 
Warrants to purchase shares of common stock   43,438    251,125    43,438    251,125 
Total potentially dilutive shares   2,550,383    1,104,095    2,550,383    1,074,953 
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net loss per share:

 

   2025   2024   2025   2024 
   Nine Months Ended September 30,   Three Months Ended September 30, 
   2025   2024   2025   2024 
                 
Net loss attributable to the common stockholders  $(2,698,254)  $(2,817,394)  $(578,503)  $(1,196,923)
                     
Basic weighted average outstanding shares of common stock   1,605,377    1,245,885    1,605,377    1,268,795 
Dilutive effect of options and warrants   -    -    -    - 
Diluted weighted average common stock and common stock equivalents   1,605,377    1,245,885    1,605,377    1,268,795 
                     
Loss per share:                    
Basic and diluted  $(1.68)  $(2.26)  $(0.36)  $(0.94)